Henlius Gets Green Light For Adalimumab In China

Company Expands Biosimilars Portfolio With Its Third Monoclonal Antibody

 
• By Akriti Seth
China_thumbsup
Henlius gets its third biosimilar approved for the Chinese market • Source: Shutterstock

More from Products

More from Generics Bulletin